Mentice's AGM adopted 2025 financials and re-elected board
No dividend was paid, and the board was authorized to issue up to 2.8 million new shares for expansion financing.
See the latest news and media coverage for Mentice. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical simulation solutions for image-guided interventional therapies
mentice.comLast updated
In short: Mentice entered a strategic co-marketing partnership with Siemens Healthineers and reported strong Q1 2026 growth with a 50.2% rise in orders.
No dividend was paid, and the board was authorized to issue up to 2.8 million new shares for expansion financing.
Order intake rose 50.2% organically to 59.0 MSEK. EBITDA improved to -9.2 MSEK. CFO and COO departed; new CFO appointed. Board changes occurred.
The meeting occurs on 26 May 2026 at 1:00 p.m. in Gothenburg. It covers reports, elections, remuneration guidelines, and share issue authorization.
The presentation by CEO Frans Venker and CFO Ulrika Drotz occurs on May 7, 2026, at 10:00 CEST, followed by Q&A. Register via DNBCarnegie.
Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing...
The consensus estimate for Q1 2026 revenue is $0.06 billion, and the earnings are expected to come in at -$0.25 per share. The full year...
Mentice, which is a supplier of simulation technology for surgeons, announces that Rick van Veen will take office as new financial director from July 1, 2026.
Earnings call Mentice reported Q4 net sales of SEK 91 million (organic growth 18%), with full-year sales at SEK 279 million (up 3% YoY, FX-adjusted...
Track Mentice and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Mentice and other trending companies.